abstract |
The present invention relates to novel pyrimidine, pyrrolo-pyrimidine, pyrrolo-pyridine, pyridine, purine and triazine compounds which are able to modulate epidermal growth factor receptor (EGFR), including Herkinases, and the use of such compounds in the treatment of various diseases, disorders or conditions. |